share_log
Benzinga ·  May 2 08:04
Allarity Therapeutics Shares Are Trading Higher After the Company Announced That Stenoparib Shows a Clear Clinical Benefit, Leading to Early Conclusion of the Phase 2 Trial in Advanced Ovarian Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment